Clinical Trial Update: Reandron in Diabetic Men Witn Low Testosterone Level [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for Reandron in men with type 2 diabetes and hypogonadism; Phase 2/3 study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism
• Type 2 Diabetes Mellitus

Drugs mentioned

• Reandron (testosterone undecanoate)

Snippet

Sponsor: Austin Health | Conditions: Type 2 Diabetes, Hypogonadism | Phase 2, Phase 3 | Status: COMPLETED